Zoetis Inc. Short-term Debt
Zoetis Inc. (ZTS) had Short-term Debt of $0 as of 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Short-Term Debt
us-gaap:ShortTermBorrowings · last filed 2025-02-13
- 2024-12-31: Short-term Debt $0.00.
- 2024-09-30: Short-term Debt $0.00.
- 2024-06-30: Short-term Debt $0.00.
- 2024-03-31: Short-term Debt $24.00M.
| Period end | Short-term Debt |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-04 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 |
| 2024-03-31 | $24.00M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $3.00M 10-K · filed 2025-02-13 |
| 2023-09-30 | $2.00M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $3.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $2.00M 10-K · filed 2024-02-13 |
| 2022-09-30 | $3.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.00M 10-Q · filed 2022-08-04 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-14 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $4.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.00M 10-K · filed 2022-02-15 |
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.00M 10-Q · filed 2020-08-06 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-16 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-06 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 |
| 2018-12-31 | $9.00M 10-K · filed 2020-02-13 |
| 2017-07-02 | $100.00M 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |